Could a simple drink fix a complication of cancer surgery?
NCT ID NCT06820320
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial tested whether taking iohexol by mouth can treat chylous ascites, a leak of lymphatic fluid that can happen after abdominal or pelvic cancer surgery. The study enrolled 42 patients who developed this condition after surgery. The goal was to see if oral iohexol could stop the fluid buildup quickly and safely, potentially offering a simpler alternative to more invasive treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- iohexol (a contrast agent taken by mouth)
- What this could lead to
- If it works, this could offer a simple, non-surgical treatment for chylous ascites after cancer surgery, reducing the need for more invasive procedures.
- What could go wrong
- This is a small, early-phase trial with only 42 participants. The results may not apply to all patients, and the safety and effectiveness need confirmation in larger studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL MALIGNANT TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immune drug outsmart Hard-to-Treat tumors?
- New study tracks gut health and confusion in malnourished cancer surgery patients
- Smart hydration during surgery may shield Seniors' brains
- New ultrasound technique could sharpen diagnosis for Kids' belly issues
- Budget laparoscope could transform cancer diagnosis in Low-Resource countries